Entinostat in patients with relapsed or refractory abdominal neuroendocrine tumors

Jamison, J. K., Zhou, M., Gelmann, E. P., Luk, L., Bates, S. E., Califano, A., & Fojo, T. (2024). Entinostat in patients with relapsed or refractory abdominal neuroendocrine tumors. The Oncologist. https://doi.org/10.1093/oncolo/oyae118
Authors:
Jacob K. Jamison
Mengxi Zhou
Edward P. Gelmann
Lyndon Luk
Susan E. Bates
Andrea Califano
Tito Fojo
Affiliated Authors:
Mengxi Zhou
Lyndon Luk
Susan E. Bates
Andrea Califano
Tito Fojo
Columbia Affiliation:
Subjects:
Epidemiology and Management of Neuroendocrine Tumors (OpenAlex Topic)
Small Cell Lung Cancer (OpenAlex Topic)
Diagnosis and Management of Gestational Trophoblastic Disease (OpenAlex Topic)
Author Keywords:
entinostat
gep-net
hdac inhibitors
neuroendocrine tumor
tumor growth rate
elink
Publication Type:
Article
Unique ID:
10.1093/oncolo/oyae118
PMID:
38886159
DOI:
10.1093/oncolo/oyae118
Journal:
Oncologist
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record
View PubMed Record
View Web of Science Record
View Scopus Record

Record Created: